Related Experiment Video
Updated: Jun 4, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic analysis in cardiovascular disease: a clinical perspective
Edwin Ho1, Ravinay Bhindi, Euan A Ashley
1North Shore Heart Research Group, Kolling Institute of Medical Research, University of Sydney, NSW, Australia.
Cardiology in Review
|February 3, 2011
Summary
Genetic factors significantly influence cardiovascular diseases (CVD), from simple Mendelian traits to complex conditions like coronary artery disease. Understanding these genetic underpinnings aids in risk assessment and targeted treatment strategies.
Area of Science:
- Genetics
- Cardiology
- Medical Research
Background:
- Cardiovascular diseases (CVD) exhibit significant heritability.
- Family history is crucial for assessing complex CVDs like coronary artery disease and hypertension.
- Advances in genetic research are clarifying the basis of both simple and complex CVDs.
Purpose of the Study:
- To review the current understanding of genetic contributions to cardiovascular diseases.
- To discuss methods for identifying genetic causes of CVD.
- To explore the clinical implications of genetic discoveries in CVD.
Main Methods:
- Literature review of genetic studies on CVD.
- Analysis of genetic approaches for identifying disease-related genes.
- Discussion of clinical applications and risk assessment modifications.
Main Results:
- Major gene disorders and complex CVDs like coronary artery disease have identifiable genetic bases.
- Genetic analysis offers potential to refine individual disease risk calculations.
- Genetic insights can guide targeted therapeutic interventions for CVD.
Conclusions:
- Genetic factors play a vital role across the spectrum of cardiovascular diseases.
- Understanding genetic predispositions is essential for personalized CVD management.
- Future research should focus on integrating genetic data into clinical practice for improved patient outcomes.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...